Catholic Healthcare West v. Kathleen Sebelius
748 F.3d 351
D.C. Cir.2014Background
- Catholic Healthcare West (CHW) acquired Marian Medical Center in an August 1997 statutory merger; CHW later claimed Medicare recoupment for alleged under-depreciation taken by Marian before the merger.
- Regulations allowed adjustment for gains or losses on disposition of depreciable assets for dispositions before Dec. 1, 1997, but only where the transfer reflected a “bona fide sale” between unrelated parties and reasonable consideration was exchanged (42 C.F.R. § 413.134 and related provisions).
- CHW’s appraiser produced three valuation approaches: cost (replacement cost less depreciation), market, and income; CMS relied on the cost approach and added working capital to estimate Marian’s fair market value at roughly $67 million.
- The actual consideration in the merger was $32.7 million (assumption of liabilities), yielding a large disparity between consideration and the CMS valuation.
- CMS (Administrator) concluded the transaction was not a bona fide sale and disallowed recoupment; CHW appealed through the PRRB and district court; the D.C. Circuit reviewed de novo and affirmed.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether the merger constituted a "bona fide sale" such that depreciation recoupment is appropriate | CHW: The merger revealed inadequate prior depreciation; alternate valuation methods (income, market) show smaller disparity and support a bona fide sale | Sec.: The implicit price (assumed liabilities) is far below Marian’s true worth; cost-based valuation shows gross disparity so no bona fide sale | Court: Affirmed Sec.; even using CHW’s most favorable income/market figures, a large disparity remains, so no bona fide sale |
| Whether CMS permissibly used a cost (replacement-cost) approach and PM guidance to exclude income/market approaches | CHW: Secretary’s reliance on PM and cost method was arbitrary and imposed without notice-and-comment | Sec.: CMS reasonably applied cost approach per guidance; prior cases have upheld PM’s interpretation | Court: Did not decide whether PM was procedurally defective; found outcome would be the same under CHW’s methods, so no reversible error |
| Burden of proof on bona fide sale question | CHW: Argued appraisal supports bona fide sale | Sec.: CHW bears burden to prove bona fide sale; disparity undercuts its proof | Court: CHW bears burden; record does not show bona fide sale in face of sizable disparity |
| Whether new oral-argument evidence (accounts receivable collectability) can be considered | CHW: Argued at oral argument that much of the $15.9M cash was accounts receivable and not fully collectible, narrowing disparity | Sec.: CMS did not have opportunity to address that new argument | Held: Court declined to consider new argument raised at oral argument and found no clear error by CMS |
Key Cases Cited
- Tenet HealthSystems HealthCorp. v. Thompson, 254 F.3d 238 (D.C. Cir.) (standard of review for agency decisions)
- Pharm. Research & Mfrs. of Am. v. Thompson, 362 F.3d 817 (D.C. Cir.) (APA standard for setting aside agency action)
- St. Luke's Hosp. v. Sebelius, 611 F.3d 900 (D.C. Cir.) (upholding Secretary's reasonable-consideration interpretation)
- Forsyth Mem'l Hosp., Inc. v. Sebelius, 639 F.3d 534 (D.C. Cir.) (burden on provider to prove bona fide sale)
- Molycorp, Inc. v. EPA, 197 F.3d 543 (D.C. Cir.) (agency may not amend rule under guise of reinterpretation)
- SEC v. Chenery Corp., 318 U.S. 80 (U.S.) (courts may not uphold agency on new grounds not articulated by agency)
- Via Christi Reg'l Med. Ctr., Inc. v. Leavitt, 509 F.3d 1259 (10th Cir.) (discussion of reasonable consideration requirement)
- Roth v. Dept. of Justice, 642 F.3d 1161 (D.C. Cir.) (declining to consider arguments first raised at oral argument)
- City of Portland v. EPA, 507 F.3d 706 (D.C. Cir.) (prejudicial error rule under APA)
- PDK Labs., Inc. v. DEA, 362 F.3d 786 (D.C. Cir.) (agency decision review principles)